KD News

Kyndryl Holdings (KD) Securities Class Action Pending, Company Files Amended Quarterly and Fiscal Year Reports Detailing Material Internal Control Weaknesses After 3 Key Executives Depart- Hagens Berman

Robbins LLP Urges KD Stockholders Who Lost Money Investing in Kyndryl Holdings, Inc. to Contact the Firm for Information About Leading the Class Action

Bronstein, Gewirtz & Grossman LLC Urges Kyndryl Holdings, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

Kyndryl Holdings, Inc. (KD) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Kyndryl Holdings, Inc. (KD)

Important Notice to Long-Term Shareholders of Corcept Therapeutics, Inc. (NASDAQ: CORT); Kyndryl Holdings (NYSE: KD); Molina Healthcare, Inc. (NYSE: MOH); and Unicycive Therapeutics, Inc. (NASDAQ: UNCY): Grabar Law Office Investigates Claims on Your Behalf

Portnoy Law Firm Announces Class Action on Behalf of Kyndryl Holdings, Inc. Investors

Scaling AI Safely Will Define Success for Healthcare Leaders in 2026

KYNDRYL HOLDINGS, INC. (KD) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Kyndryl Holdings, Inc. Investors of Upcoming Deadline

Kyndryl Holdings, Inc. (KD) Investors: April 13, 2026 Filing Deadline in Securities Class Action - Contact Lieff Cabraser